Minireviews
Copyright ©The Author(s) 2022.
World J Clin Cases. Sep 6, 2022; 10(25): 8808-8815
Published online Sep 6, 2022. doi: 10.12998/wjcc.v10.i25.8808
Table 1 Following coronavirus disease 2019 immunizations, some studies observed otorhinolaryngological problems
Ref.
Country
Date
Number of cases
Symptoms
Vaccine
Colella et al[49]ItalyFebruary 20211Left Bell’s palsyFirst dose of Pfizer
Repajic et al[50]United StatesFebruary 20211Left Bell’s palsySecond dose of Pfizer
Konstantinidis et al[25]Greece GermanyMay 20212Hyposmia Second dose of Pfizer
Keir et al[51]United StatesJune 20211PhantosmiaSecond dose of Pfizer
Lechien et al[52]France Belgium ItalySeptember 20216Smell abnormalities (n = 5); taste abnormality (n = 1)The first injection of AstraZeneca (n = 4); a second injection of Pfizer (n = 2)
Wichova et al[53]United StatesOctober 202130Hearing loss (25), vertigo (5), dizziness (8), tinnitus (15)Moderna (n = 18), Pfizer (n = 12)
Jeong and Choi[54]KoreaDecember 20213SSNHLOne case after Oxford-AstraZeneca, 2 cases after Pfizer